| Popis: |
Respiratory devices have been the mainstay of treatment for obstructive sleep apnea for decades. However, despite significant technical advances in mechanisms of enhancing patient tolerance, many patients with severe disease have remained deprived of treatment. Alternative treatments for this population were largely unavailable until the introduction of upper airway stimulation therapy. By stimulating the hypoglossal nerve, this therapy activates muscles innervating the intrinsic and extrinsic muscles of the tongue, thus addressing inadequate neural activation. Since its commercial introduction, this innovative therapy has been adopted by multiple medical groups in North America and in Europe. |
